Baidu
map

Blood:胚系TET2功能丧失性突变导致儿童免疫缺陷和淋巴瘤

2020-06-13 QQY MedSci原创

免疫先天缺陷的分子解剖有助于阐明个体基因的非冗余功能。Spegarova等研究了三名患有免疫失调综合征的儿童,这些儿童表现为易感染、淋巴结病、肝脾肿大、发育迟缓、自身免疫和B细胞或T细胞来源的淋巴瘤(

免疫先天缺陷的分子解剖有助于阐明个体基因的非冗余功能。Spegarova等研究了三名患有免疫失调综合征的儿童,这些儿童表现为易感染、淋巴结病、肝脾肿大、发育迟缓、自身免疫和B细胞或T细胞来源的淋巴瘤(B细胞的2位,T细胞的1位)。在异基因造血干细胞移植后,这三位患儿都出现了早期的自体T细胞重建。
 
通过全外显子测序,研究人员在DNA羟甲基化酶TET2中发现了罕见的、纯合的、胚系错义或无义变异。TET2可将RNA上的5-甲基胞嘧啶(5mC)催化形成5-羟甲基胞嘧啶(5hmC),在开启天然免疫反应方面具有重要功能。

突变的TET2蛋白不表达或存在5-羟甲基化活性酶促缺陷,导致血液DNA整体高甲基化。在两位患儿中,循环T细胞表现出异常的免疫表型,包括双阴性细胞扩增、滤泡辅助性T细胞腔衰竭,以及Fas依赖性凋亡受损。此外,TET2缺失的B细胞表现出类开关样的重组缺陷。患儿来源的诱导多能干细胞的造血潜能向髓系细胞倾斜。

这是人类首次报道的导致临床显著的免疫缺陷和自身免疫性淋巴增生综合征,且有明显的淋巴瘤易感性的常染色体隐性胚系TET2缺陷的病例。这种疾病的表型进一步支持TET2在人类免疫系统中的具有广泛的作用

原始出处:

Jarmila Stremenova Spegarova,et al. Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma. Blood. June 9,2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2011427, encodeId=375d201142ec1, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Sun Nov 01 16:55:57 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446534, encodeId=0ecd144653408, content=<a href='/topic/show?id=2c001e30276' target=_blank style='color:#2F92EE;'>#TET2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17302, encryptionId=2c001e30276, topicName=TET2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeee5221880, createdName=neurowu, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488996, encodeId=f5051488996a8, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602183, encodeId=883060218320, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/69b5882b3c3845c19efa131b4ff8b1f7/06ccd8f1857e4e14862049ab235618eb.jpg, createdBy=74c72110107, createdName=qinqiyun, createdTime=Sat Jun 13 15:57:09 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-11-01 yhy100200
  2. [GetPortalCommentsPageByObjectIdResponse(id=2011427, encodeId=375d201142ec1, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Sun Nov 01 16:55:57 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446534, encodeId=0ecd144653408, content=<a href='/topic/show?id=2c001e30276' target=_blank style='color:#2F92EE;'>#TET2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17302, encryptionId=2c001e30276, topicName=TET2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeee5221880, createdName=neurowu, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488996, encodeId=f5051488996a8, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602183, encodeId=883060218320, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/69b5882b3c3845c19efa131b4ff8b1f7/06ccd8f1857e4e14862049ab235618eb.jpg, createdBy=74c72110107, createdName=qinqiyun, createdTime=Sat Jun 13 15:57:09 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-06-15 neurowu
  3. [GetPortalCommentsPageByObjectIdResponse(id=2011427, encodeId=375d201142ec1, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Sun Nov 01 16:55:57 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446534, encodeId=0ecd144653408, content=<a href='/topic/show?id=2c001e30276' target=_blank style='color:#2F92EE;'>#TET2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17302, encryptionId=2c001e30276, topicName=TET2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeee5221880, createdName=neurowu, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488996, encodeId=f5051488996a8, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602183, encodeId=883060218320, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/69b5882b3c3845c19efa131b4ff8b1f7/06ccd8f1857e4e14862049ab235618eb.jpg, createdBy=74c72110107, createdName=qinqiyun, createdTime=Sat Jun 13 15:57:09 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2011427, encodeId=375d201142ec1, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Sun Nov 01 16:55:57 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446534, encodeId=0ecd144653408, content=<a href='/topic/show?id=2c001e30276' target=_blank style='color:#2F92EE;'>#TET2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17302, encryptionId=2c001e30276, topicName=TET2)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aeee5221880, createdName=neurowu, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488996, encodeId=f5051488996a8, content=<a href='/topic/show?id=7df32913871' target=_blank style='color:#2F92EE;'>#免疫缺陷#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29138, encryptionId=7df32913871, topicName=免疫缺陷)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631b8488299, createdName=rebeccajiejie, createdTime=Mon Jun 15 06:55:57 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602183, encodeId=883060218320, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/69b5882b3c3845c19efa131b4ff8b1f7/06ccd8f1857e4e14862049ab235618eb.jpg, createdBy=74c72110107, createdName=qinqiyun, createdTime=Sat Jun 13 15:57:09 CST 2020, time=2020-06-13, status=1, ipAttribution=)]
    2020-06-13 qinqiyun

    学习了

    0

相关资讯

Nat Genet:TET2如何被招募到染色质?王建龙组从RNA结合蛋白角度给出部分答案

有关TET家族蛋白参与DNA去甲基化的作用及其相关的生物学功能这里不再赘述,相信关注生物学的同行多少都会有些了解。尽管,过去将近十年的时间里,有非常多的关于TET蛋白的研究报道,但是有一些生物学问题很长时间都没有被很好的解决。

Blood:Bcor剂量不足可促进骨髓增生异常综合征的发生发展

中心点:Bcor剂量不足会促进骨髓增生异常综合征的发生发展。在骨髓增生异常综合征的病理过程中,Bcor剂量不足与Tet2缺失相互协作。摘要:BCOR,编码BCL-6共抑制剂(BCOR),与X染色体连锁,是多种血液恶性肿瘤(包括骨髓增生异常综合征)的体细胞突变靶点。Shiro Tara等人既往发现造血室缺失Bcor4号外显子的小鼠(BcorΔE4/y)会进展出NOTCH依赖性的急性T细胞淋巴细胞白血

Cell :复旦教授破译TET2蛋白三维结构,有望用于白血病药物研发

经过逾4年的研究,复旦大学生物医学研究院徐彦辉课题组首次成功解析了哺乳动物骨髓造血关键蛋白TET2的三维结构,这将对血液肿瘤(即血癌、白血病)治疗性药物的开发具有重大意义。上述成果昨日(6日)已在线发表于国际顶级学术期刊《细胞》杂志上,引起世界同行广泛关注。哺乳动物TET蛋白家族有3个成员,即TET1蛋白、TET2蛋白和TET3蛋白。TET蛋白在哺乳动物发育和骨髓造血等关键生命过程中,扮演至关重

Cell:复旦大学研究院解析骨髓造血关键蛋白TET2三维结构

复旦大学生物医学研究院研究员徐彦辉课题组经4年多研究,首次成功解析了哺乳动物骨髓造血关键蛋白TET2的三维结构。该成果对研究多种疾病的发病机制,尤其对血液肿瘤(如髓系白血病)治疗性药物开发有重大意义。相关论文日前在线发表在国际学术期刊《细胞》杂志上。 哺乳动物TET蛋白家族有3个成员,即TET1蛋白、TET2蛋白和TET3蛋白,在哺乳动物发育和骨髓造血等关键生命过程

Blood:TET2缺陷促进异常红系祖细胞克隆扩增,导致无效造血

骨髓增生异常综合征(MDS)是克隆性造血干细胞失调,特点是无效造血。贫血是MDS患者的典型细胞减少症,但MDS异常红系造血的分子机制尚不完全清楚。近期有研究表明DNA双加氧酶TET2杂合功能丧失性突变是MDS最常见的突变之一,TET2缺陷可扰乱红系分化。但是,TET2在红系生成障碍中的作用机制尚未完全明确。Xiaoli Qu等人发现TET2缺陷最初会导致干细胞因子(SCF)依赖性的过度增殖,并损伤

Baidu
map
Baidu
map
Baidu
map